1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NIDDK High Risk, High Impact Research is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. NIDDK supports high-risk, high-impact research to advance understanding and treatment of kidney diseases. Development of a bioartificial kidney would be considered high-impact research.
This would likely be pursued through general NIH funding mechanisms (e.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Advancing Research & Health for All Enfermedad de los riñones Griffin P. Rodgers, M. D.
, M. A. C.
P. Heterogeneity of Diabetes Review recommendations from the NIDDK’s Working Group of Council on Heterogeneity of Diabetes. An updated article on infections associated with diabetes is available now.
Pathway to Kidney Recovery: Optimizing Outcomes in Acute Kidney Injury Requiring Dialysis Accelerating the Translation of Cell Therapy for Type 1 Diabetes Data Management & Sharing (DMS) Guidance, Tools and Resources NIDDK researchers can refer to NIDDK guidance for writing a DMS plan. NIDDK Labs Offer Research Training Opportunities Join our vibrant community at one of the most prestigious research institutions in the world.
Behavioral intervention decreases how much pain affects daily activities in people with dialysis-dependent kidney failure NIH study demonstrates long-term benefits of weight-loss surgery in young people Genomic variants that increase risk of kidney disease are found in nearly one-third of West Africans First wave of COVID-19 increased risk of heart attack, stroke up to three years later Work side-by-side with leading NIH scientists.
Where to register and what to do before you apply for a funding opportunity Research Training & Career Development NIDDK offers and participates in a variety of opportunities for researchers. Is Participating in Clinical Trials Right for You? Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.
Learn more about clinical trials Diabetes and Continuous Glucose Monitoring Talk to your doctor about continuous glucose monitoring to help manage your diabetes. Managing Chronic Kidney Disease Learn about the causes and complications of chronic kidney disease. Understanding Hepatitis D Discover the causes, symptoms, and treatment plan for Hepatitis D.
According to the current listing, eligibility includes: Researchers at eligible institutions, generally including academic, non-profit, and for-profit organizations, with projects deemed high risk and high impact by NIH criteria. Confirm the full requirements in the official notice before applying.
NIDDK High Risk, High Impact Research is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs from NIDDK are competitive federal grant programs administered by the National Institute of Diabetes and Digestive and Kidney Diseases supporting innovative research by small businesses with potential for commercialization. NIDDK participates in both SBIR and STTR programs, with funding opportunities aligned to its mission areas in diabetes, digestive diseases, and kidney diseases. Eligible applicants are U.S. small businesses with innovative research applicable to NIDDK's scientific program areas. The NIH SEED website provides comprehensive application guidance and NIDDK-specific program contacts.
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. This program encourages applications to plan multi-center clinical studies. While not specific to bioartificial kidneys, research planning for such complex medical devices would fall under clinical study implementation.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article